​

Atea Pharmaceuticals (AVIR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Atea Pharmaceuticals Revenue Highlights

00

Atea Pharmaceuticals Revenue by Period

Atea Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--100.00%
2021-12-31$351.37M622.49%
2020-12-31$48.63M100.00%
2019-12-31-100.00%
2018-12-31--

Atea Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Atea Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$416.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$192.18M485.72%
2021-09-30$32.81M-45.67%
2021-06-30$60.39M-8.48%
2021-03-31$65.98M35.68%
2020-12-31$48.63M100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Atea Pharmaceuticals generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Atea Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TRDAEntrada Therapeutics$210.78M$1.61M
VNDAVanda Pharmaceuticals$198.77M$56.26M
ARCTArcturus Therapeutics$152.31M$17.15M
VYGRVoyager Therapeutics$80.00M$13.37M
ENTAEnanta Pharmaceuticals$65.32M$18.31M
PYXSPyxis Oncology$16.15M-
ALLOAllogene Therapeutics$22.00K-
HUMAHumacyte-$753.00K
ACHVAchieve Life Sciences--
AVIRAtea Pharmaceuticals--

AVIR Revenue FAQ

What is Atea Pharmaceuticals’s yearly revenue?

Atea Pharmaceuticals's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. AVIR's yearly revenue for 2022 was $0, representing a decrease of -100.00% compared to 2021.

What is Atea Pharmaceuticals’s quarterly revenue?

Atea Pharmaceuticals's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). AVIR's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Atea Pharmaceuticals’s revenue growth rate?

Atea Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -100.00%.